Oncological Websites
Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer an
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
3,446,235
$
480.00
SEPT: System Effect Potentiation Therapy - Cancer Treatment
SEPT is a treatment that can cure cancer with a high probability.
Not Applicable
$
8.95
Norwich Medical Search Portal | Norwich Radiology Search Portal
Norwich Medical Search Portal is a resource for medical researchers and academia
Not Applicable
$
8.95
